iPerf announces that €7 million has been successfully raised in seed funding over the period 2021-2023. This round has enabled iPerf to build a strong team, validate the performance of its device, prepare its first clinical study and its access to the US market (preparation in progress).
iPerf changes its visual identity, with a new logo, a new graphic charter, a website and a presence on social networks.
The iPerf team led by prof. Pierre Mordant, MD PhD at Hôpital Bichat in Paris has published an article in the Journal of Clinical Medicine entitled: “Preventing Acute Limb ischemia during VA-ECMO – In Silico Analysis of Physical Parameters Associated with Lower Limb Perfusion”.
American College of Cardiology’s 75rd Annual Scientific Session: Dr Sylvain Beurtheret and Pr Pierre Mordant, members of iPerf’s Scientific Advisory Board, presented the results of their research on: “ Adverse Impact of Vascular Complications in Patients with Cardiogenic Shock and Extra Corporeal Membrane Oxygenation “. This real-life study analyzes in detail the vascular complications of…
Now that the design of the innovative cannula has been completed, and validation tests on the prototypes carried out, iPerf has ordered its first pre-series of cannulas for the Clinical Study and First In Human.